Experimental cancer drug that targets gene mutation can shrink tumours, reports new study in Nature. Eight out of 10 mice became cancer free with a high dose. Four people with non-small-cell lung carcinoma also received the drug. One person had their tumour shrink by 34$%, and the other by 67%.